Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
Read more at MarketWatch
-
Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin
Business - MarketWatch - November 7 -
Roblox’s stock soars on third-quarter bookings beat and raised guidance
Business - MarketWatch - October 31 -
TJX boosted by strength in Europe, as retailer posts earnings beat and raises guidance
Business - MarketWatch - 21 hours ago -
Freshpet’s stock jumps premarket after earnings beat and company raises guidance
Business - MarketWatch - November 4 -
Southwest Airlines beats on revenue by a wide margin, names new board members
Business - MarketWatch - October 24 -
Lowe’s CEO confident in retailer’s ability to manage Trump tariffs after earnings beat
Business - MarketWatch - 2 days ago
More from MarketWatch
-
Treasury yields steady as traders weigh increased Russia-Ukraine tensions
Business - MarketWatch - 16 minutes ago -
‘I’m at a loss’: My boyfriend of nearly 10 years is naming his elderly parents as beneficiaries and giving them power of attorney. Am I right to be upset?
Business - MarketWatch - 36 minutes ago -
‘My house is paid off’: How do I ensure my son-in-law never gets my money — even if my daughter dies before he does?
Business - MarketWatch - 44 minutes ago -
I’m 54, but my wife is already 63. Can she claim on my Social Security record as a spouse?
Business - MarketWatch - 49 minutes ago -
Oil prices near 2-week high on further escalation in Russia-Ukraine missile exchange
Business - MarketWatch - 52 minutes ago